Terug
Dagbereik
€ 9,31
€ 9,81
52-Weeksbereik
€ 9,23
€ 28,44
Volume
2.514.216
50D / 200D Gem.
€ 13,28
/
€ 19,16
Vorige Slotkoers
€ 9,57
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,9 | 0,4 |
| P/B | 0,5 | 2,9 |
| ROE % | -39,3 | 3,9 |
| Net Margin % | -33,5 | 3,8 |
| Rev Growth 5Y % | 0,7 | 10,0 |
| D/E | 1,4 | 0,2 |
Koersdoel Analisten
Hold
€ 21,50
+123.0%
Low: € 20,00
High: € 23,00
Forward K/W
4,20
Forward WPA
€ 2,28
WPA Groei (sch.)
+0,0%
Omzet Sch.
4,13B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,92
€ 2,90 – € 2,95
|
4,26B | 1 |
| FY2029 |
€ 2,82
€ 2,80 – € 2,85
|
4,21B | 1 |
| FY2028 |
€ 2,67
€ 2,64 – € 2,69
|
4,20B | 1 |
No quarterly estimates available
Dividend History
Yield
0,08%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 0,68% annually over 5 years — modest growth
Generating 145,10M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,43%
Capital efficient — spends only 2,20% of revenue on capex
ROIC of 3,73% — low return on invested capital
Groei
Revenue Growth (5Y)
0,68%
Revenue (1Y)-2,75%
Earnings (1Y)N/A
FCF Growth (3Y)-30,89%
Kwaliteit
Return on Equity
-39,29%
ROIC3,73%
Net Margin-33,51%
Op. Margin8,07%
Veiligheid
Debt / Equity
1,35
Current Ratio2,76
Interest Coverage2,11
Waardering
P/E Ratio
-0,93
Forward P/EN/A
P/B Ratio0,45
EV/EBITDA13,88
Dividend Yield0,08%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2,75% | Revenue Growth (3Y) | -4,42% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 0,68% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,25B | Net Income (TTM) | -1,43B |
| ROE | -39,29% | ROA | -16,70% |
| Gross Margin | 35,14% | Operating Margin | 8,07% |
| Net Margin | -33,51% | Free Cash Flow (TTM) | 145,10M |
| ROIC | 3,73% | FCF Growth (3Y) | -30,89% |
| Safety | |||
| Debt / Equity | 1,35 | Current Ratio | 2,76 |
| Interest Coverage | 2,11 | ||
| Dividends | |||
| Dividend Yield | 0,08% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,93 | Forward P/E | N/A |
| P/B Ratio | 0,45 | P/S Ratio | 0,31 |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | 13,88 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 10,93% | ||
| Market Cap | 1,33B | Enterprise Value | 4,76B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,25B | 4,37B | 4,66B | 4,45B | 4,14B |
| Net Income | -1,43B | -171,80M | -12,70M | -140,60M | -68,90M |
| EPS (Diluted) | -10,29 | -1,25 | -0,09 | -0,97 | -0,98 |
| Gross Profit | 1,49B | 1,54B | 1,68B | 1,46B | 1,42B |
| Operating Income | 343,30M | 112,90M | 151,90M | 78,90M | 410,40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8,54B | 9,65B | 10,81B | 11,02B | 10,43B |
| Total Liabilities | 5,60B | 5,33B | 6,04B | 6,18B | 5,27B |
| Shareholders' Equity | 2,94B | 4,32B | 4,77B | 4,84B | 5,15B |
| Total Debt | 3,97B | 3,62B | 4,07B | 4,32B | 3,69B |
| Cash & Equivalents | 531,60M | 558,80M | 751,30M | 600,70M | 1,86B |
| Current Assets | 2,80B | 2,48B | 2,83B | 2,72B | 3,86B |
| Current Liabilities | 1,01B | 1,04B | 1,59B | 1,11B | 1,59B |